Cardiff Oncology Inc (CRDF)

CapEx to Revenue

42.31%

Quarterly · Period ending:

CRDF logo

CRDF CapEx to Revenue

Latest reported42.31%
CRDF Quarterly CapEx/Revenue (0.00% → 42.31%)
High-resolution chart · PNG

CRDF capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cardiff Oncology Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
42.3077%
0%
0%
15%
21.4876%
0%
0%
0%
0%
39.0244%
5.1282%
223.4043%
232.4074%
9.6386%
58.5938%
481.7204%
342.8571%
231.0811%
80.4511%
113.9535%
0%
0%
48.7158%
113.075%
0%
0%
73.0441%
120.6261%
0%
3.0864%
6.5385%
0%
0%
5.0931%
73.6492%
93.6625%
9.1029%
12.0499%
37.7971%
142.4176%
308.3598%
292.1692%
1,245.6684%
992.5916%
881.736%
194.6105%
227.9768%
178.2636%
27.2363%
106.8083%
165.0664%
482.1259%
544.4633%
78.3652%
35.4969%
33.6884%
103.5181%
286.9704%
4.5304%
0%
0%
1.7153%
47.619%
0%
150%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.